The ELIXIR Industry Advisory Committee (IAC) provides advice and feedback on ELIXIR industry engagement activities. The committee consists of experts from the private sector ranging from SMEs to large multinational companies. Its twelve members are appointed by the ELIXIR Board.
For 2024 and 2025, the Chair of the ELIXIR IAC is Filip Pattyn, who will be supported by Catherine Sirven as Vice-Chair.
| Name | Affiliation |
|---|---|
| Ian Barrett | AstraZeneca, UK |
| Thomas Exner | Seven Past Nine GmbH, Germany |
| Richard Finkers | GenNovation B.V., the Netherlands |
| Andreas Kremer | ITTM, Luxembourg |
| Klaus Maisinger | Illumina, UK |
| Filip Pattyn (Chair) | FAQIR, Belgium |
| Elizabeth Reynolds | General Bioinformatics, UK |
| Helena Saunders | Syngenta, UK |
| Catherine Sirven (Vice-Chair) | Bayer, France |
| Bérénice Wulbrecht | argenx, Belgium |
Industry Advisory Committee (IAC)
Image
Members of the ELIXIR Industry Advisory Committee, from left to right: Joana Wingender (Hub), Despoina Sousoni (Hub), Ivana Iljasic Versic (Hub), Filip Pattyn, Catherine Sirven, Ian Barrett, Andreas Kremer, Tim Hubbart (Hub), Bérénice Wulbrecht, Geert de Meyer, Klaus Maisinger, Thomas Exner
Previous Advisory Committee meetings & reports
- 22 January 2025: Report
- 17 January 2024: Report
- 11 October 2023 (TC): Report
- 14-15 February 2023: Report
- 26 October 2022 (TC): Report
- 24 May 2022 (TC): Report
- 20 January 2022 (TC): Report
- 7 May 2021 (TC): Report
- 20 January 2021 (TC): Report
- 28 January 2020: Meeting details, Report
- 29 January 2019: Meeting details, Report
- 25 January 2018: Meeting details, Report
- 25 January 2017: Meeting details, Report
- 14 January 2016: Meeting details, Report
- 26 February 2015: Meeting details, Report